GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » EV-to-FCF

Microbot Medical (FRA:CY9D) EV-to-FCF : -1.35 (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Microbot Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Microbot Medical's Enterprise Value is €9.71 Mil. Microbot Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €-7.17 Mil. Therefore, Microbot Medical's EV-to-FCF for today is -1.35.

The historical rank and industry rank for Microbot Medical's EV-to-FCF or its related term are showing as below:

FRA:CY9D' s EV-to-FCF Range Over the Past 10 Years
Min: -60.71   Med: 0.02   Max: 5.87
Current: -1.32

During the past 13 years, the highest EV-to-FCF of Microbot Medical was 5.87. The lowest was -60.71. And the median was 0.02.

FRA:CY9D's EV-to-FCF is ranked worse than
100% of 360 companies
in the Medical Devices & Instruments industry
Industry Median: 27.515 vs FRA:CY9D: -1.32

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), Microbot Medical's stock price is €0.979. Microbot Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.822. Therefore, Microbot Medical's PE Ratio for today is At Loss.


Microbot Medical EV-to-FCF Historical Data

The historical data trend for Microbot Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical EV-to-FCF Chart

Microbot Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.40 -3.42 -4.09 -1.38 -1.52

Microbot Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 -2.12 -0.91 -1.52 -1.49

Competitive Comparison of Microbot Medical's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Microbot Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Microbot Medical's EV-to-FCF falls into.



Microbot Medical EV-to-FCF Calculation

Microbot Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9.706/-7.171
=-1.35

Microbot Medical's current Enterprise Value is €9.71 Mil.
Microbot Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbot Medical  (FRA:CY9D) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Microbot Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.979/-0.822
=At Loss

Microbot Medical's share price for today is €0.979.
Microbot Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.822.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Microbot Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Microbot Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbot Medical (FRA:CY9D) Business Description

Traded in Other Exchanges
Address
25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Microbot Medical (FRA:CY9D) Headlines

No Headlines